| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9326772 | Gynecologic Oncology | 2005 | 6 Pages |
Abstract
Neoadjuvant treatment with gemcitabine/cisplatin combination for patients with cervical cancer (stage IB2) appears encouraging, with manageable and acceptable toxicity profile.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
W. Termrungruanglert, D. Tresukosol, A. Vasuratna, T. Sittisomwong, R. Lertkhachonsuk, N. Sirisabya,